Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA VENUS REMEDIES PLETHICO PHARMA/
VENUS REMEDIES
 
P/E (TTM) x -0.1 15.0 - View Chart
P/BV x 0.0 0.9 1.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
VENUS REMEDIES
Mar-23
PLETHICO PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs254379 67.0%   
Low Rs31145 21.6%   
Sales per share (Unadj.) Rs604.6415.5 145.5%  
Earnings per share (Unadj.) Rs32.519.9 163.5%  
Cash flow per share (Unadj.) Rs51.344.0 116.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs473.7344.3 137.6%  
Shares outstanding (eoy) m34.0713.37 254.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.20.6 37.4%   
Avg P/E ratio x4.413.2 33.3%  
P/CF ratio (eoy) x2.85.9 46.7%  
Price / Book Value ratio x0.30.8 39.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,8593,501 138.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,547570 271.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,5985,555 370.8%  
Other income Rs m419103 406.4%   
Total revenues Rs m21,0175,658 371.4%   
Gross profit Rs m2,938602 488.0%  
Depreciation Rs m642323 198.9%   
Interest Rs m1,7473 59,408.8%   
Profit before tax Rs m968379 255.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138114 -121.8%   
Profit after tax Rs m1,107266 416.6%  
Gross profit margin %14.310.8 131.6%  
Effective tax rate %-14.330.0 -47.7%   
Net profit margin %5.44.8 112.4%  
BALANCE SHEET DATA
Current assets Rs m18,8773,230 584.5%   
Current liabilities Rs m11,896826 1,440.8%   
Net working cap to sales %33.943.3 78.3%  
Current ratio x1.63.9 40.6%  
Inventory Days Days7837 211.6%  
Debtors Days Days198504 39.3%  
Net fixed assets Rs m14,2692,781 513.0%   
Share capital Rs m341134 254.9%   
"Free" reserves Rs m15,7984,470 353.4%   
Net worth Rs m16,1394,603 350.6%   
Long term debt Rs m4,706387 1,216.6%   
Total assets Rs m33,1466,011 551.4%  
Interest coverage x1.6130.0 1.2%   
Debt to equity ratio x0.30.1 347.0%  
Sales to assets ratio x0.60.9 67.2%   
Return on assets %8.64.5 192.7%  
Return on equity %6.95.8 118.8%  
Return on capital %13.07.7 170.0%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,4020-   
Fx outflow Rs m3,1840-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,437366 665.5%  
From Investments Rs m-6,265-508 1,232.5%  
From Financial Activity Rs m2,490-6 -43,839.6%  
Net Cashflow Rs m24-220 -11.1%  

Share Holding

Indian Promoters % 57.8 41.8 138.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.4 1.6 1,220.8%  
FIIs % 2.7 1.6 169.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.3 58.2 72.5%  
Shareholders   16,430 19,560 84.0%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on PLETHICO PHARMA vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PLETHICO PHARMA vs VENUS REMEDIES Share Price Performance

Period PLETHICO PHARMA VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -4.91% 7.05% 1.18%
1-Month -1.24% -4.10% -0.75%
1-Year -70.21% 103.11% 61.82%
3-Year CAGR -66.86% 4.62% 18.16%
5-Year CAGR -51.20% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the PLETHICO PHARMA share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of PLETHICO PHARMA hold a 57.8% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PLETHICO PHARMA and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, PLETHICO PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of PLETHICO PHARMA, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.